Latest News

Sammok S-Form Co.,Ltd's ( KOSDAQ:018310 ) earnings announcement last week didn't impress shareholders. However, our...

Shareholders appeared unconcerned with CLIO Cosmetics Co.,Ltd's ( KOSDAQ:237880 ) lackluster earnings report last week...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Uniform Next Co., Ltd.'s ( TSE:3566 ) robust earnings report didn't manage to move the market for its stock. We did...

Soft earnings didn't appear to concern CJ Seafood Corporation's ( KRX:011150 ) shareholders over the last week. We...

Lion Corporation ( TSE:4912 ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

Investors were underwhelmed by the solid earnings posted by Messe eSang Co.,Ltd ( KOSDAQ:408920 ) recently. We did some...

Metallium Limited ( ASX:MTM ) is possibly approaching a major achievement in its business, so we would like to shine...

Cencora (NYSE:COR) has signed a binding agreement to acquire the retina division of EyeSouth Partners, expanding its Retina Consultants of America network. The transaction centers on advanced retina care services and is intended to deepen Cencora's presence in ophthalmology-focused healthcare offerings. The company also announced the planned retirement of Chief Financial Officer James F. Cleary and has initiated an executive search for his successor. Cencora operates across pharmaceutical...

In late March 2026, activist short seller Morpheus Research released a report alleging that MakeMyTrip violated regulatory bans on price parity clauses and raised questions about accounting practices, including the treatment of a receivable from insolvent airline Go Air. The report also highlighted a large gap between MakeMyTrip’s adjusted profits and IFRS figures, bringing renewed attention to the company’s financial transparency and regulatory exposure. We’ll now explore how these...

KalVista Pharmaceuticals recently reported new interim results from its KONFIDENT-KID trial, showing that EKTERLY (sebetralstat) oral disintegrating tablets treated 172 hereditary angioedema attacks in 33 children aged 2–11 with rapid symptom relief and no serious or treatment-related adverse events. The data highlight how an easy-to-administer oral option could address a major gap in pediatric hereditary angioedema care, where current on-demand treatment for young patients in the US is...

Analyst downgrades and CEO exit put Adobe’s risk profile in focus Recent downgrades of Adobe (ADBE) and the planned retirement of long-serving CEO Shantanu Narayen have put leadership, pricing power, and AI competition at the center of the stock’s story for investors. Several research houses, including William Blair, have questioned how resilient Adobe’s Creative Cloud economics are as free or low cost design tools and AI native rivals gain traction, even as the company continues to invest...

Wondering whether Reply is starting to look attractively priced after a tough run, or if the current share price still leaves questions on value. Reply shares last closed at €82.05, after a recent 5% gain over 7 days but still showing a 9.1% decline over 30 days and a 26.0% decline year to date, with a 44.0% decline over the past year. These moves have put valuation and risk firmly in focus for investors, especially as longer term performance over 3 and 5 years, at 24.5% and 22.8% declines...

CME Group (NasdaqGS:CME) reports record trading volumes across all product categories. The company launches 24/7 trading for regulated cryptocurrency futures and options. CME partners with BMO and Google Cloud to roll out 24/7 tokenized cash settlement for institutional clients. CME Group, trading at $305.11, is drawing attention after reporting all time record volumes across multiple asset classes and pushing further into round the clock trading. The stock is up 13.1% year to date and...

SmartCentres Real Estate Investment Trust finalized new five year arrangements with Penguin Group, reinforcing its core operating partnership. The Executive Chairman and CEO has agreed to extend his leadership of SmartCentres through December 2030. An independent committee of trustees unanimously recommended the agreements, which have now been approved. For investors watching TSX:SRU.UN, this governance update adds fresh context to a unit price that most recently closed at CA$27.41. The...

Millicom International Cellular: Recent Performance Snapshot Millicom International Cellular (TIGO) has caught investor attention after a strong run, with the stock showing gains over the past week, month and past 3 months that outpace its recent daily move. With a recent close of $79.64 and a market value of about $12.88b, investors are weighing this price action against Millicom’s reported $5,819.0 in revenue, $1,316.0 in net income and a value score of 5. See our latest analysis for...

Fermi Inc., in partnership with the Texas Tech University System, recently arranged up to US$156.25 million in unsecured debt financing alongside a US$165.00 million equipment loan, while advancing permitting and regulatory filings for its large-scale Project Matador energy campus in Texas. These moves, paired with a US$486.38 million net loss in 2025 and plans for up to ~17 GW of generation including nuclear, gas, solar, and batteries, highlight Fermi’s push to build a privately funded...

Eli Lilly (LLY) has surged back into the spotlight after the FDA approved Foundayo, a once daily oral GLP 1 pill for obesity that expands the company’s weight loss portfolio beyond injectables. See our latest analysis for Eli Lilly. The FDA approval of Foundayo comes after an already active period for Eli Lilly, with recent acquisitions in neuroscience and new data across dermatology and psoriatic arthritis. Over the same time, the share price has seen a 30 day return of 7.16% and a 90 day...

If you are wondering whether Pool's current share price lines up with its underlying value, this article walks through the numbers so you can judge that for yourself. Pool last closed at US$202.93, with returns of 0.9% over 7 days, an 8.3% decline over 30 days, an 11.7% decline year to date and a 34.1% decline over 1 year that many investors are watching closely. Over the past few months, coverage of Pool has focused on how the share price performance compares with broader retail...

Escalating geopolitical tensions are driving fresh attention to Elbit Systems' role in drone and electronic warfare. Recent material updates highlight stronger global demand for advanced unmanned systems and electronic warfare platforms. Elbit Systems, TASE:ESLT, is being cited as a key supplier as militaries reassess modernization priorities. Elbit Systems, TASE:ESLT, operates across unmanned aerial systems, electronic warfare equipment, and broader defense technologies. Recent...

Multiple law firms and investor groups have launched class action lawsuits against Nektar Therapeutics (NasdaqCM:NKTR). The suits allege securities fraud tied to protocol violations in the Phase 2b REZOLVE-AA trial. Claims focus on whether Nektar misled investors about enrollment and data integrity for this alopecia areata study. These legal actions introduce new uncertainty around the company’s clinical programs and governance practices. Nektar Therapeutics focuses on developing drug...

Comcast Xfinity is in a carriage dispute with E.W. Scripps that has triggered immediate blackouts of major broadcast networks and key sports programming in several U.S. markets. At the same time, Comcast has entered a partnership with NVIDIA to deploy real-time AI applications at the network edge across parts of its infrastructure. Both developments are material for NasdaqGS:CMCSA investors because they touch core video services, customer experience, and future network...

In late March 2026, On Holding AG announced a leadership shake-up effective May 1, 2026, with co-founders David Allemann and Caspar Coppetti becoming Co-CEOs, long-time CEO and former CFO Martin Hoffmann stepping down into an advisory role, and Frank Sluis joining as the new CFO. The reorganization places the founders directly in charge of day-to-day execution while elevating President & COO Scott Maguire to oversee the entire value chain, potentially tightening the link between product...

In March 2026, NGK Insulators, Ltd. raised its year-end dividend forecast for the fiscal year ending March 31, 2026 to ¥42 per share, lifting the expected annual dividend to ¥80 per share, citing steady performance in its Environment and Digital Society businesses. This dividend revision underlines management’s emphasis on shareholder returns, including a medium-term goal of a 3% dividend on equity ratio and a consolidated payout ratio around 30%. Next, we’ll examine how NGK’s higher...